We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.46B
AUM Growth
+$46.3M
(+1.4%)
Cap. Flow
-$206M
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
500
New
53
Increased
40
Reduced
235
Closed
55
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$68.5M |
| 2 |
Ross Stores
ROST
|
+$43.1M |
| 3 |
Vistance Networks Inc
VISN
|
+$40.4M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$34.5M |
| 5 |
Hershey
HSY
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$73.4M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$66.7M |
| 3 |
IQVIA
IQV
|
+$58.8M |
| 4 |
Target
TGT
|
+$56M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.76% |
| 2 | Consumer Discretionary | 17.48% |
| 3 | Healthcare | 16.31% |
| 4 | Industrials | 13.3% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Gulf Island Fabrication
GIFI
| $736K | 0.02% |
63,700
-510
| -0.8% | -$6.29K |
2015 Q3
6 quarters
|
|
177
Genesco
GCO
$405M
| $698K | 0.02% |
+12,580
| New | +$750K |
2017 Q1
0 quarters
|
|
178
Exelixis
EXEL
$15.4B
| $637K | 0.02% |
29,380
-30
| -0.1% | -$610 |
2015 Q3
6 quarters
|
|
179
Ultragenyx Pharmaceutical
RARE
$1.44B
| $586K | 0.02% |
8,650
-10
| -0.1% | -$762 |
2015 Q4
5 quarters
|
|
180
Interparfums
IPAR
$3.74B
| $585K | 0.02% |
16,000
+1,200
| +8% | +$41.6K |
2016 Q4
1 quarter
|
|
|
KITE
181
DELISTED
Kite Pharma, Inc.
KITE
| $545K | 0.02% |
6,940
-194
| -3% | -$12K |
2015 Q4
5 quarters
|
|
|
BSTC
182
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $536K | 0.02% |
9,788
| – | – |
2014 Q1
12 quarters
|
|
|
BRSS
183
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $530K | 0.02% |
15,420
-83,150
| -84% | -$2.83M |
2015 Q4
5 quarters
|
|
|
CVG
184
DELISTED
Convergys
CVG
| $502K | 0.01% |
23,750
-70,590
| -75% | -$1.66M |
2016 Q3
2 quarters
|
|
185
DELISTED
Sage Therapeutics
SAGE
| $493K | 0.01% |
6,940
-10
| -0.1% | -$586 |
2016 Q4
1 quarter
|
|
186
Ironwood Pharmaceuticals
IRWD
$595M
| $488K | 0.01% |
34,125
-23
| -0.1% | -$314 |
2016 Q1
4 quarters
|
|
187
Commercial Vehicle Group
CVGI
$113M
| $480K | 0.01% |
70,840
| – | – |
2016 Q2
3 quarters
|
|
188
Archrock
AROC
$5.18B
| $478K | 0.01% |
38,510
-1,100
| -3% | -$15.4K |
2016 Q2
3 quarters
|
|
189
First Community Bankshares
FCBC
$926M
| $474K | 0.01% |
19,000
| – | – |
2013 Q2
15 quarters
|
|
190
Lantheus
LNTH
$6.53B
| $465K | 0.01% |
37,170
| – | – |
2016 Q3
2 quarters
|
|
191
Stock Yards Bancorp
SYBT
$2.4B
| $461K | 0.01% |
11,335
| – | – |
2013 Q3
14 quarters
|
|
192
DELISTED
Exact Sciences
EXAS
| $456K | 0.01% |
19,320
-20
| -0.1% | -$396 |
2016 Q2
3 quarters
|
|
193
REX American Resources
REX
$1.38B
| $456K | 0.01% |
30,240
| – | – |
2014 Q3
10 quarters
|
|
194
World Acceptance Corp
WRLD
$816M
| $443K | 0.01% |
8,560
| – | – |
2013 Q2
15 quarters
|
|
195
First Financial Corp
THFF
$890M
| $439K | 0.01% |
9,250
| – | – |
2014 Q2
11 quarters
|
|
|
CLVS
196
DELISTED
Clovis Oncology, Inc.
CLVS
| $436K | 0.01% |
6,840
| – | – |
2016 Q4
1 quarter
|
|
197
US Physical Therapy
USPH
$1.28B
| $433K | 0.01% |
6,637
| – | – |
2013 Q2
15 quarters
|
|
198
Wabash National
WNC
$526M
| $418K | 0.01% |
20,192
-3,910
| -16% | -$76.6K |
2015 Q1
8 quarters
|
|
199
Ligand Pharmaceuticals
LGND
$5.87B
| $415K | 0.01% |
6,284
-16
| -0.3% | -$1.05K |
2016 Q1
4 quarters
|
|
200
Pathward Financial
CASH
$1.52B
| $401K | 0.01% |
13,590
| – | – |
2016 Q4
1 quarter
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Smith Group Asset Management held 500 positions worth $3.46B, up 1.4% from $3.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Smith Group Asset Management withdrew a net $206M in Q1 2017, closing 55 positions and reducing 235 holdings. Its most notable exit was Red Hat Inc, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Smith Group Asset Management opened a new position in Celgene Corp worth $71.3M.
- Smith Group Asset Management's largest Q1 2017 buy was Celgene Corp: 572,792 shares worth $71.3M.
- Smith Group Asset Management added most to US Bancorp in Q1 2017, an estimated $22.7M increase.
- Smith Group Asset Management's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $73.4M.
- Smith Group Asset Management fully exited Red Hat Inc in Q1 2017, selling an estimated $66.7M.
- Smith Group Asset Management's ten largest holdings make up 25% of its $3.46B portfolio in Q1 2017.
- Smith Group Asset Management opened 53 new positions and closed 55 in Q1 2017.
- Smith Group Asset Management's portfolio value rose 1.4% quarter-over-quarter to $3.46B.
Based on Smith Group Asset Management's 13F filing for Q1 2017, filed 4 May 2017.